Published in J Immunol on November 01, 1984
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A (1999) 5.28
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med (2003) 1.56
B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med (2002) 1.20
Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity. Clin Exp Immunol (2001) 1.12
In vitro production of interleukin-4 and interferon-gamma by lymph node cells from BALB/c mice infested with nymphal Ixodes ricinus ticks. Immunology (1995) 1.05
CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge. J Immunol (2009) 1.05
A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J Exp Med (2004) 0.99
Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am J Pathol (2008) 0.97
Dendritic cells and T cells transfer sensitization for delayed-type hypersensitivity after skin painting with contact sensitizer. Immunology (1989) 0.97
Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP. Immunology (1989) 0.96
Effect of a Trichinella spiralis infection on the distribution of mast cell precursors in tissues of thymus-bearing and non-thymus-bearing (nude) mice determined by an in vitro assay. Immunology (1987) 0.90
A sequential study of the bovine tuberculin reaction. Immunology (1996) 0.90
Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hypersensitivity reactions at mucosal surfaces. Clin Exp Immunol (1991) 0.87
Airway hyper-reactivity mediated by B-1 cell immunoglobulin M antibody generating complement C5a at 1 day post-immunization in a murine hapten model of non-atopic asthma. Immunology (2004) 0.86
Differing role of dendritic cells and macrophages in the induction of delayed-type hypersensitivity responses to PPD. Immunology (1986) 0.86
Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity. Immunology (2006) 0.85
Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity. J Immunol Res (2014) 0.81
Induction of delayed-type hypersensitivity responses to PPD: dendritic cells in synergy with 5-hydroxytryptamine can substitute for macrophages. Immunology (1988) 0.80
Kinetics of murine delayed-type hypersensitivity response to Eimeria falciformis (Apicomplexa: Eimeriidae). Infect Immun (1989) 0.79
Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of either mast cells or macrophages for elicitation of the response. Immunology (1993) 0.79
Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity. Immunology (2001) 0.77
MD41, a novel T helper 0 clone, mediates mast-cell dependent delayed-type hypersensitivity in mice. Immunology (2002) 0.77
The absence of delayed-type hypersensitivity reactivity in a syngeneic murine tumour system. Immunology (1987) 0.76
Hepatitis B surface antigen induces an early-type hypersensitivity. Clin Exp Immunol (1991) 0.75
Pharmacologic manipulation of a four day murine delayed type hypersensitivity model. Agents Actions (1993) 0.75
Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med (1975) 5.42
Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J Exp Med (1975) 2.91
Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol (1997) 2.79
Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. J Exp Med (1982) 2.48
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke (1999) 2.28
Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03
Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med (1980) 1.99
Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells. J Immunol (1978) 1.96
Role of basophils, mast cells, and vasoamines in hypersensitivity reactions with a delayed time course. Prog Allergy (1977) 1.80
Solid phase radioimmunoassay of human beta 1C globulin. Immunochemistry (1970) 1.77
T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med (1980) 1.65
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J Immunol (1984) 1.55
Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet (1978) 1.49
An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med (1983) 1.45
Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol (1982) 1.45
The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J Immunol (1977) 1.45
Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Cell Mol Biol (1997) 1.43
Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol (1983) 1.42
Cutaneous basophil hypersensitivity in contact-sensitized guinea pigs. I. Transfer with immune serum. J Exp Med (1973) 1.42
Differential release of serotonin and histamine from mast cells. Nature (1982) 1.37
Cytophilic antibodies in mice contact-sensitized with oxazolone. Immunochemical characterization and preferential binding to a trypsin-sensitive macrophage receptor. Immunology (1974) 1.37
Contact sensitivity to oxazolone in the mouse. VIII. Demonstration of several classes of antibody in the sera of contact sensitized and unimmunized mice by a simplified antiglobulin assay. Immunology (1972) 1.36
Colonic basophil hypersensitivity. J Immunol (1978) 1.29
IgE-dependent release of leukotriene C4 from alveolar macrophages. Nature (1982) 1.29
Evanescent delayed-type hypersensitivity: mediation by effector cells with a short life span. J Immunol (1977) 1.28
Transfer of an antigen-specific immediate hypersensitivity-like reaction with an antigen-binding factor produced by T cells. Proc Natl Acad Sci U S A (1982) 1.24
Cutaneous basophil hypersensitivity uncovered in the cell transfer of classical tuberculin hypersensitivity. J Immunol (1976) 1.23
Air pollution is associated with increased level of exhaled nitric oxide in nonsmoking healthy subjects. Arch Environ Health (1999) 1.23
Basophils and eosinophils in three strains of rats and in athymic (nude) rats following infection with the nematodes Nippostrongylus brasiliensis or Trichinella spiralis. Immunology (1980) 1.23
Effects of fever on host defense mechanisms after infection in the lizard Dipsosaurus dorsalis. Br J Exp Pathol (1978) 1.22
A newly described activity of guinea pig IgG1 antibodies: transfer of cutaneous basophil reactions. J Immunol (1978) 1.21
Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nat Biotechnol (1997) 1.20
T-cell-mediated induction of airway hyperreactivity in mice. Am Rev Respir Dis (1991) 1.18
Allergen-specific Th1 cells counteract efferent Th2 cell-dependent bronchial hyperresponsiveness and eosinophilic inflammation partly via IFN-gamma. J Immunol (2001) 1.16
Cutaneous basophil anaphylaxis. Immediate vasopermeability increases and anaphylactic degranulation of basophils at delayed hypersensitivity reactions challenged with additional antigen. Immunology (1978) 1.16
Ixodes dammini: induced skin lesions in guinea pigs and rabbits compared to erythema chronicum migrans in patients with lyme arthritis. Exp Parasitol (1982) 1.15
Gamma delta T cells assist alpha beta T cells in adoptive transfer of contact sensitivity. J Immunol (1992) 1.15
Diesel exhaust particles induced release of interleukin 6 and 8 by (primed) human bronchial epithelial cells (BEAS 2B) in vitro. Exp Lung Res (1998) 1.15
Contaminant-related suppression of delayed-type hypersensitivity and antibody responses in harbor seals fed herring from the Baltic Sea. Environ Health Perspect (1995) 1.14
T cells produce an antigen-binding factor with in vivo activity analogous to IgE antibody. J Exp Med (1983) 1.14
Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells. J Exp Med (1997) 1.14
Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J Immunol (1991) 1.13
Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor. Lab Invest (1984) 1.12
Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol (1995) 1.12
Contaminant-induced immunotoxicity in harbour seals: wildlife at risk? Toxicology (1996) 1.10
Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity. J Immunol (1996) 1.09
Simultaneous generation of tuberculin-type and cutaneous basophilic hypersensitivity at separate sites in the guinea pig. Int Arch Allergy Appl Immunol (1979) 1.09
Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity. J Immunol (1996) 1.08
Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines. Immunology (1982) 1.08
Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation (1999) 1.07
Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J Allergy Clin Immunol (1999) 1.03
Antibody-mediated basophil accumulations in cutaneous hypersensitivity reactions of guinea pigs. J Immunol (1976) 1.03
Endothelial cell E- and P-selectin up-regulation in murine contact sensitivity is prolonged by distinct mechanisms occurring in sequence. J Immunol (1999) 1.03
Immunotoxic effects of TCDD and toxic equivalency factors. Teratog Carcinog Mutagen (1998) 1.02
Chemicals trophic for the thymus: risk for immunodeficiency and autoimmunity. Int J Immunopharmacol (1992) 1.02
Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J Immunol (1991) 1.02
Diffuse glomerulonephritis in rabbits with Streptococcus viridans endocarditis. Lab Invest (1975) 1.02
Macrophages in solid tumors. I. Immunologically specific effector cells. J Natl Cancer Inst (1974) 1.02
Improvement of the in vitro T cell proliferation assay by a modified method that separates the antigen recognition and IL-2-dependent steps. J Immunol Methods (1987) 1.01
Amblyomma americanum: physiochemical isolation of a protein derived from the tick salivary gland that is capable of inducing immune resistance in guinea pigs. Exp Parasitol (1986) 1.00
Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur J Immunol (1984) 0.99
Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity. J Immunol (1992) 0.99
Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J Immunol (1997) 0.99
An isometric method to study respiratory smooth muscle responses in mice. J Pharmacol Methods (1990) 0.98
Cutaneous basophil responses and immune resistance of guinea pigs to ticks: passive transfer with peritoneal exudate cells or serum. J Immunol (1981) 0.98
Cuta neous basophil responses in neonatal guinea pigs: active immunization, hapten specific transfer with small amounts of serum, and preferential elicitation with phytohemagglutinin skin testing. J Immunol (1977) 0.98
Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2. J Biol Chem (1992) 0.97
Postviral myositis: myxovirus-like structures in affected muscle. Ann Intern Med (1977) 0.96
Use of micrometers and calipers to measure various components of delayed-type hypersensitivity ear swelling reactions in mice. J Immunol Methods (1984) 0.96
Transpetrosal access to meningiomas juxtaposing the temporal bone. Laryngoscope (1994) 0.96
A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol (1989) 0.96
A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors. J Immunol (1985) 0.96
Studies on the role of the thymus and T cells in the in vivo suppression of delayed hypersensitivity (desensitization): radiosensitivity of the mechanism inducing nonspecific anergy. J Immunol (1977) 0.96
Suppression of T cell-mediated cutaneous basophil hypersensitivity by serum from guinea pigs immunized with mycobacterial adjuvant. J Exp Med (1982) 0.95
UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology (1999) 0.95
Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-gamma production in vitro. J Exp Med (1996) 0.94
Basophils in human disease. Clin Rev Allergy (1983) 0.94
Nylon adherent antigen-specific rosette-forming T cells. J Exp Med (1977) 0.93
Immunotoxicity of bis(tri-n-butyltin)oxide in the rat: effects on thymus-dependent immunity and on nonspecific resistance following long-term exposure in young versus aged rats. Toxicol Appl Pharmacol (1990) 0.92
Effects of silica on macrophages and lymphocytes. J Reticuloendothel Soc (1977) 0.92
Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem Pharmacol (1985) 0.91
Alterations in the cortical thymic epithelium of rats after in vivo exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): an (immuno)histological study. Toxicol Appl Pharmacol (1992) 0.91
Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique. J Immunol (1986) 0.91
Effects of pesticide exposure on the human immune system. Hum Exp Toxicol (2008) 0.89
Adoptive cell transfer of contact sensitivity-initiation mediated by nonimmune cells sensitized with monoclonal IgE antibodies. Dependence on host skin mast cells. J Immunol (1995) 0.89
A review of studies on the effects of ultraviolet irradiation on the resistance to infections: evidence from rodent infection models and verification by experimental and observational human studies. Int Immunopharmacol (2002) 0.89
Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. J Immunol (2000) 0.89
Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation. Cell Tissue Res (1990) 0.88